Admin Core - Britton
管理核心 - 布里顿
基本信息
- 批准号:10583458
- 负责人:
- 金额:$ 24.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-01 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:Antibiotic ResistanceAntimicrobial ResistanceBacteriophagesCommunicationCommunitiesCoordination and CollaborationDataDecision MakingFosteringFundingGrantInternationalMedical centerMedicineMissionMonitorMucous MembraneNational Institute of Allergy and Infectious DiseasePathway interactionsPilot ProjectsReagentResearchResearch PersonnelResearch Project GrantsSourceStructureSurfaceTechnologyTexasUnited States National Institutes of HealthWorkcollegecombatcommunity centerdesignexperiencemeetingsmicrobiomemicrobiotaoutreachprogramssynergismtimeline
项目摘要
Project Summary.
The BCM-CARBIRU Administrative Core is structured to provide a framework for the integration of
the three research projects and the two scientific cores, a plan for scientific and fiscal management,
and a steering committee to facilitate decision making on key topics by the project leaders. This
project will be directed by Dr. Britton and he will serve as the administrative liaison with the NIH. Dr.
Maresso and Dr. Lemon will serve as co-directors as this is a multi-PI proposal between the three
investigators. A detailed plan for the interaction of the BCM-CARBIRU team is provided, as well as a
plan to engage the broader Baylor College of Medicine and Texas Medical Center community in
combating antimicrobial resistance. To stimulate this interaction, we propose a pilot project program
with matching funds from Baylor College of Medicine to augment the research proposed in the BCM-
CARBIRU.
项目摘要。
BCM-CARBIRU行政核心的结构是提供一个框架,
三个研究项目和两个科学核心,一个科学和财政管理计划,
以及一个指导委员会,以协助项目负责人就关键主题作出决策。这
该项目将由布里顿博士指导,他将担任与NIH的行政联络人。博士
Maresso和Lemon博士将担任联合董事,因为这是三人之间的多PI提案
investigators.提供了BCM-CARBIRU团队互动的详细计划,以及
计划让更广泛的贝勒医学院和德克萨斯医疗中心社区参与进来,
对抗抗菌素耐药性。为了促进这种互动,我们提出了一个试点项目计划,
与贝勒医学院的配套资金,以加强在2010年提出的研究,
卡比鲁。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT A BRITTON其他文献
ROBERT A BRITTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT A BRITTON', 18)}}的其他基金
Multi-method investigation and characterization of the ocular microbiome
眼部微生物组的多方法研究和表征
- 批准号:
10660691 - 财政年份:2023
- 资助金额:
$ 24.02万 - 项目类别:
Engineered probiotic for the treatment of autoimmune diseases
用于治疗自身免疫性疾病的工程益生菌
- 批准号:
10561101 - 财政年份:2023
- 资助金额:
$ 24.02万 - 项目类别:
Defined microbial communities to prevent and eradicate infection by AMR pathogens
定义微生物群落以预防和根除 AMR 病原体感染
- 批准号:
10357969 - 财政年份:2021
- 资助金额:
$ 24.02万 - 项目类别:
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces
微生物组的发现和对抗粘膜表面抗生素耐药性的机制
- 批准号:
10357964 - 财政年份:2021
- 资助金额:
$ 24.02万 - 项目类别:
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces
微生物组的发现和对抗粘膜表面抗生素耐药性的机制
- 批准号:
10583457 - 财政年份:2021
- 资助金额:
$ 24.02万 - 项目类别:
Defined microbial communities to prevent and eradicate infection by AMR pathogens
定义微生物群落以预防和根除 AMR 病原体感染
- 批准号:
10583468 - 财政年份:2021
- 资助金额:
$ 24.02万 - 项目类别:
Diet driven evolution of epidemic ribotypes of Clostridium difficile
饮食驱动艰难梭菌流行性核糖型的进化
- 批准号:
10053311 - 财政年份:2017
- 资助金额:
$ 24.02万 - 项目类别:
相似海外基金
The epidemiology of transmissible antimicrobial resistance among Shigella species
志贺菌属中传播性抗菌药物耐药性的流行病学
- 批准号:
MR/X000648/1 - 财政年份:2024
- 资助金额:
$ 24.02万 - 项目类别:
Research Grant
Intended and unintended consequences of the ZnO ban from pig diets on antimicrobial resistance, post-weaning diarrhoea and the microbiome
猪日粮中禁用氧化锌对抗菌素耐药性、断奶后腹泻和微生物组的有意和无意的影响
- 批准号:
BB/Y003861/1 - 财政年份:2024
- 资助金额:
$ 24.02万 - 项目类别:
Research Grant
Engineering Nature-based Solutions to Tackle Antimicrobial Resistance
工程基于自然的解决方案来解决抗菌素耐药性
- 批准号:
EP/Y003101/1 - 财政年份:2024
- 资助金额:
$ 24.02万 - 项目类别:
Research Grant
Roles of emerging pollutants in spreading antimicrobial resistance
新出现的污染物在传播抗菌素耐药性方面的作用
- 批准号:
DE240100842 - 财政年份:2024
- 资助金额:
$ 24.02万 - 项目类别:
Discovery Early Career Researcher Award
Environmental Reservoirs and Antimicrobial Resistance in Non-tuberculosis Mycobacteria: A Genomic Investigation
非结核分枝杆菌的环境储库和抗菌素耐药性:基因组研究
- 批准号:
502471 - 财政年份:2024
- 资助金额:
$ 24.02万 - 项目类别:
A novel anti-biofilm peptide from fish for the combat against antimicrobial resistance
一种来自鱼类的新型抗生物膜肽,用于对抗抗菌素耐药性
- 批准号:
MR/Y503393/1 - 财政年份:2024
- 资助金额:
$ 24.02万 - 项目类别:
Research Grant
Active one health surveillance in LMICs to monitor and predict Antimicrobial Resistance Using Metagenomics (ALARUM)
在中低收入国家中开展主动单一健康监测,利用宏基因组学 (ALARUM) 监测和预测抗菌药物耐药性
- 批准号:
MR/Y034287/1 - 财政年份:2024
- 资助金额:
$ 24.02万 - 项目类别:
Research Grant
Intended and unintended consequences of the ZnO ban from pig diets on antimicrobial resistance, post-weaning diarrhoea and the microbiome.
猪日粮中禁用氧化锌对抗菌素耐药性、断奶后腹泻和微生物组的有意和无意的影响。
- 批准号:
BB/Y004108/1 - 财政年份:2024
- 资助金额:
$ 24.02万 - 项目类别:
Research Grant
A Cell-Free Toolbox to Anticipate, Learn and Counter Antimicrobial Resistance
预测、学习和对抗抗菌素耐药性的无细胞工具箱
- 批准号:
BB/Y005074/1 - 财政年份:2024
- 资助金额:
$ 24.02万 - 项目类别:
Research Grant
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
- 批准号:
EP/Z533026/1 - 财政年份:2024
- 资助金额:
$ 24.02万 - 项目类别:
Research Grant